×

SYSTEMS AND METHODS FOR DETERMINING INSULIN THERAPY FOR A PATIENT

  • US 20130165901A1
  • Filed: 12/21/2012
  • Published: 06/27/2013
  • Est. Priority Date: 12/21/2011
  • Status: Active Grant
First Claim
Patent Images

1. A non-transitory computer readable medium having stored therein instructions executable by a computing device to cause the computing device to perform functions comprising:

  • receiving information associated with a glucose measurement value of a patient;

    receiving information associated with anticipated nutrition intake for the patient;

    receiving information indicating a short-acting insulin-on-board for the patient, wherein short-acting insulin-on-board is associated with an amount of short-acting insulin that remains in the patient due to a prior insulin administration;

    based, at least in part, on the information associated with the glucose measurement value of the patient, the anticipated nutrition intake for the patient and the short-acting insulin-on-board, determining at least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof;

    receiving information indicating a confirmation of a nutrition intake for the patient;

    receiving information indicating a long-acting insulin-on-board for the patient, wherein long-acting insulin-on-board is associated with an amount of long-acting insulin that remains in the patient due to a prior insulin administration;

    based, at least in part, on the information associated with the long-acting insulin-on-board for the patient, the glucose measurement value of the patient, and the confirmation of the nutrition intake for the patient, determining a required long-acting subcutaneous or intravenous insulin dosage for the patient;

    adjusting the short-acting subcutaneous insulin dosage or intravenous insulin dosage recommendation based on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage; and

    outputting an indication of at least one of the required long-acting subcutaneous insulin dosage, the adjusted short-acting subcutaneous or intravenous insulin dosage recommendation, the intravenous insulin dosage recommendation, the correction subcutaneous insulin dosage recommendation, the recommended amount of carbohydrates to be administered to the patient, or combinations thereof.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×